Beneficial effects of iloprost cardioplegia in ischemic arrest in isolated working rat heart

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 54, Issue 4, 1996, Pages 279-283

  Feng, Jun ^a   Wu, Guozen ^b   Tang, Shuben ^c   Chahine, Ramez ^a   Lamontagne, Danial ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b First Teaching Hospital   (China)

^c ZHENGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPLEGIC AGENT; ILOPROST; PROSTACYCLIN DERIVATIVE; THROMBOXANE A2; THROMBOXANE B2;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA FLOW; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART ARREST; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART PRESERVATION; HEART STROKE VOLUME; HYPOTHERMIA; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALIA;

EID: 0029977306     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90059-9     Document Type: Article

References (31)

1. Ohlendorf R., Perzborn E., Schror K. Prevention of ischemia induced decrease in platelet count by prostacyclin. Thromb Res 1980; 19: 447-453.
2. 2) cardioplegic infusion improve myocardial protection after ischémie arrest? Ann Thorac Surg 1985; 40: 368-373.
3. Jugdutt B. I., Hutchins G. M., Bulakley B. H. et al. Dissimilar effects of prostacyclin, prostaglandin E on myocardial infarction size after coronary occlusion in conscious dogs. Circ Res 1981; 49: 685-700.
4. Ogletree N. L., Lefer A. M., Smith J. B., Nicolaou K. C. Studies on the protective effect of prostacyclin in acute myocardial ischemia. Eur J Pharmacol 1979; 56: 95-103.
5. Schror K., Ohlendorf R., Darius H. Beneficial effects of a new carbacyclin derivative, ZK 36374, in acute myocardial ischemia. J Pharmacol Exp Ther 1981; 219: 243-249.
6. Darius H., Hossmann V., Schror K. Antiplatelet effects of intravenous iloprost patients with peripheral arterial obliterative disease. Klin Wochenschr 1986; 64: 545-551.
7. Morton B. C., Mclaughlin P. R., Trimble A. S. et al. Myocardial infarction in coronary artery surgery. Circulation 1975; 51 (suppl 1): 198.
8. Langen R. A., Wils J. C., Peduzzi P. N. et al. Incidence and mortality of perioperative myocardial infarction in patients undergoing coronary artery bypass grafting. Circulation 1977; 56 (suppl 2): 54.
9. Weisel R. D., Hoy F. B., Baird R. J. et al. Comparison of alternative cardioplegic techniques. J Thorac Cardiovasc Surg 1983; 86: 97-100.
10. Christlieb I. Y., Clark R. E., Nora J. D. et al. Marked limitation of ischemic reperfusion injury by nifedipine. Circulation 1978; 58 (suppl 2): 11.
11. Elgebaiy S., Kozol R., Masetti P. et al. Release of neutrophil chemotactic factors from ischemic myocardial tissues. Forum 1987; 38: 276-279.
12. Allan G., Levi R. Thromboxane and prostacyclin release during cardiac immediate hypersensitivity reactions in vitro. J Pharmacol Exp Ther 1981; 217: 157-161.
13. Neely J. R., Liebrmeister N., Battersby E. J., Morgan H. E. Effect of pressure development oxygen consumption by the isolated rat heart. Am J Physiol 1976; 212: 804-814.
14. Ledingham S. J. M., Braimbridge M. V., Hearse D. J. The St. Thomas' hospital cardioplegic solution: a comparison of the efficacy of two formulations. J Thorac Cardiovasc Surg 1987; details.
15. 2. J Su Zhou Medical School. 1986; 6: 13.
16. Feinberg H., Rosenbaum D. S., Levitsky S. et al. Platelet deposition after surgically induced global myocardial ischemia: an etiologic factor for reperfusion injury. J Thorac Cardiovasc Surg 1982; 84: 815-822.
17. Rosenbaum D., Levitsky S., Silverman N. et al. Cardioplegia does not prevent reperfusion injury induced by intracoronary platelet deposition. Circulation 1983; 68 (suppl 2): 102-106.
18. Kobina G., Laraia P., D'Ambra M. et al. Effect of experimental cardiopulmonary bypass on systemic and transcardiac thromboxane B level. J Thorac Cardiovasc Surg 1986; 91: 852-857.
19. 2 in blood vessels walls and its physiological significance: relevance to thrombosis and hypertension. Prostaglandins Med 1980; 4: 431-438.
20. Stahl R., Deutsch E., Fishes C. et al. Cardiac ischemia and endothelial function in the isolated rabbit heart. J Surg Res 1989; 47: 97-104.
21. Keller A., Clancy R., Barr M. et al. Acute reoxygenation injury in the isolated rat heart: Role of resident cardiac mast cells. Circ Res 1988; 63: 1044-1052.
22. Mehta J., Mehta P. Prostacyclin and thromboxane A production by human cardiac atrial tissues. Am Heart J 1985; 109: 1-3.
23. 2 synthetase activities during ischemia and reperfusion in isolated rabbit heart. Prostaglandins Leukot Essent Fatty Acids 1991; 261-266.
24. Kalsnet S. The effect of hypoxia on prostaglandin output and on tone in isolated coronary arteries. Can J Physiol Pharmacol 1977; 55: 882.
25. Kreisel L., Schaper J. The effect of transient global ischemia on capillaries of human hearts. Circulation 1980; 62 (suppl 1): 14.
26. Carppentier S., Murawsky M. Cytotoxicity of cardioplegic solution evaluation by tissue culture. Circulation 1981; 64 (suppl 3): 90.
27. Sinzinger, Feigl W., Silberbauer K. Prostacyclin generation in atherosclerotic arteries. Lancet 1979; 2: 469.
28. Darius H., Osborne J. A., Reibel D. K., Lefer A. M. Protective actions of a stable prostacyclin analog in ischemia induced membrane damage in rat myocardium. J Mol Cell Cardiol 1983; 15: 118-121.
29. Thiemermann C. E., Steinhagen T. E., Schror K. Inhibition of oxygen-centered free radical formation by the stable prostacyclin-mimetic iloprost (ZK36374) in acute myocardial ischemia. J Cardiovasc Pharmacol 1984; 6: 365-366.
30. Smith E. F., Kloster G., Schror K. Effects of iloprost (ZK36374) on membrane intergrity in ischemic rabbit hearts. Biomed Biochem Acta 1984; 43: 155-158.
31. 2 prevents ischemia induced alterations in cardiac catecholamine release in nonischemic conditions. J Cardiovasc Pharmacol 1982; 4: 741-748.